Article
Streamlining Eligibility Assessment for Alzheimer’s Disease-Modifying Therapies: Prediction of MMSE Scores Using the Digital Clock and Recall
2026-03-04
Abstract excerpt
<h4>Introduction</h4> The eligibility of anti-amyloid disease-modifying therapies (DMTs) and their integration into clinical practice in some institutions requires a specific range of Mini-Mental State Examination (MMSE) scores. Reliance on this pencil-and-paper psychometric instrument imposes operational burdens and risks perpetuating health disparities due to the test’s known educational and cultural biases. Th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3245c265-3a30-5f23-93ca-95be7d0a0e92
- DOI
- 10.64898/2026.03.03.26347542
